Treatment of bacterial vaginosis: what we have and what we miss.
about
Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a reviewThe role of infection in miscarriageEpidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China.BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trialComparison of the Effects of Myrtus Communis L, Berberis Vulgaris and Metronidazole Vaginal Gel alone for the Treatment of Bacterial Vaginosis.Comparison between the efficacy of metronidazole vaginal gel and Berberis vulgaris (Berberis vulgaris) combined with metronidazole gel alone in the treatment of bacterial vaginosis.A comparison of the efficacy of metronidazole vaginal gel and Myrtus (Myrtus communis) extract combination and metronidazole vaginal gel alone in the treatment of recurrent bacterial vaginosis.Impact of antiseptics on Chlamydia trachomatis growth.Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study.A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.Recent advances in the prevention of preterm birth.Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal.Newly Isolated Lactobacilli strains from Algerian Human Vaginal Microbiota: Lactobacillus fermentum Strains Relevant Probiotic's Candidates.Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.
P2860
Q26778387-0ED8E388-C391-4F9A-84E6-55BF67182214Q26783142-FD52A248-7CC8-455B-9C86-270931E02562Q33713068-E7675F4A-4A4C-4706-A1D6-998C12A050E4Q35888829-57904CE2-B648-4839-AB01-D6E980FA220BQ36831182-5C5EFCEC-071D-4450-B114-66C49E743F69Q37316927-870E36AC-05F3-475A-A02A-543A90141477Q37707833-68FC9BBC-5D4C-4A0C-99AA-2973A9646FB6Q37835922-369DE06A-4ED3-40B1-87A7-7AE3D9297BDDQ38851896-034093FC-544B-4735-8220-666F94EE991AQ39020204-88F85C3C-BCD8-4C64-8421-396D826D080CQ40998075-0E5AC830-6E7A-45ED-95A5-35AC0B0AD5C2Q41056880-5EF5DF6B-DA82-4945-9B54-5F04EA02B36AQ41588595-BC4F1C3D-645D-4C47-90D4-4F6633DB66C6Q47353492-1E758E7B-6EEE-48A1-AA46-482387E8E10AQ47583539-EC7790F9-539E-411D-AB9E-DD9788434B3D
P2860
Treatment of bacterial vaginosis: what we have and what we miss.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of bacterial vaginosis: what we have and what we miss.
@ast
Treatment of bacterial vaginosis: what we have and what we miss.
@en
Treatment of bacterial vaginosis: what we have and what we miss.
@nl
type
label
Treatment of bacterial vaginosis: what we have and what we miss.
@ast
Treatment of bacterial vaginosis: what we have and what we miss.
@en
Treatment of bacterial vaginosis: what we have and what we miss.
@nl
prefLabel
Treatment of bacterial vaginosis: what we have and what we miss.
@ast
Treatment of bacterial vaginosis: what we have and what we miss.
@en
Treatment of bacterial vaginosis: what we have and what we miss.
@nl
P2860
P1476
Treatment of bacterial vaginosis: what we have and what we miss.
@en
P2093
Dace Rezeberga
P2860
P304
P356
10.1517/14656566.2014.881800
P407
P577
2014-02-28T00:00:00Z